Search
Showing results for "8"
News & Events
Some heroes wear capes. Some heroes wear lab coats. And some heroes wear school uniforms, just like you!Ten-year-old Isabelle decided to make and sell loom band bracelets to raise money for The Kids Research Institute Australia.
Enhancing psychological wellbeing in families from pregnancy to infancy
Research
Ultra low dose CT screen-detected non-malignant incidental findings in the Western Australian Asbestos Review ProgrammeThe prevalence of LDCT-detected indeterminate lung nodules in 906 individuals with significant asbestos exposure was 8.5%, lower than many other CT studies
Research
Protocol For Study Of Information Needs Of Parents Of Infants Newly Diagnosed With Cystic FibrosisThis study aimed to investigate the information needs, priorities, and information-seeking behaviours of parents of infants newly diagnosed with CF.
Research
Contrasting effects of prenatal life stress on blood pressure and bodymass index in young adultsThe effect of prenatal life stress on BP was accentuated by a higher BMI. Fetal programming events as a result of prenatal stress may underpin some of these...
Research
A conceptual framework for comprehensive rheumatic heart disease control programsThe World Health Organization, World Heart Federation, and other organizations recommend comprehensive control programs for rheumatic fever (RF) and...
Research
A molecular dynamics study of C1r and C1s dimers: Implications for the structure of the C1 complexComplement is an important part of the immune system. It is initiated through three different pathways known as the classical, lectin, and alternative pathway.
Research
Transition to parentingPregnancy marks the transition from childlessness to parenthood, and provides an opportunity for parents-to-be to prepare, research and reflect.
News & Events
Supporting Families Project UpdateIn early 2024, Dr Aveni Haynes and her team were awarded Telethon Trust funding for their project Supporting Families.
Research
Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab ProphylaxisNirsevimab is a long-acting monoclonal antibody used to prevent respiratory syncytial virus (RSV) infection in infants and high-risk children. During the 2024 RSV season in Western Australia, 21 922 doses were administered to infants entering their first season and 1221 doses to at-risk children. In this context, the selection and spread of escape variants are a potential concern. This study aimed to investigate nirsevimab binding site mutations using clinical and wastewater data.